 |
J&J to acquire Israel's Omrix for $465mJohnson & Johnson Inc will acquire Israel's Omrix Biopharmaceuticals Inc for $27 a share, or a total of $465 million, the Globes financial news website said on Monday. Omrix, which makes biosurgical sealants for the prevention of b More… |
Monday 23 December 2024
